Skip to content
← Full study record

NCT01098266 · MORE INFO

Limitations, agreements, and source contact

NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed · Source last updated 2019-09-17

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
false
restrictive Agreement
true
point Of Contact
email
clinical.operations@molmed.com
organization
Molmed S.p.A
phone
003902212771
title
Clinical Operations
Complete source fields
certain Agreement
pi Sponsor Employee
false
restrictive Agreement
true
point Of Contact
email
clinical.operations@molmed.com
organization
Molmed S.p.A
phone
003902212771
title
Clinical Operations

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice